Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC
Home > About the journal

Started in 1982


pISSN: 1000-467X

eISSN: 1944-446X

CN: 44-1195/R


Supervisor

Ministry of Education, P. R. China

Sponsor

Sun Yat-sen University Cancer Center


Chinese Journal of Cancer (《癌症》) publishes original research, reviews, extra views, perspectives, supplements, and spotlights in all areas of cancer research. The primary criteria for publication in CJC are originality, outstanding scientific merit, and general interest. The Editorial Board is composed of members from around the world, who will strive to maintain the highest standards for excellence in order to generate a valuable resource for an international readership.


Editorial Board


Honorary Editor-in-Chief

Yi-Xin Zeng
Beijin Hospital, China

 

Editor-in-Chief

Rui-Hua Xu
Sun Yat-sen University Cancer Center, China

Associate Editors

Chao-Nan Qian
Sun Yat-sen University Cancer Center, China

Wei Zhang
University of Texas MD Anderson Cancer Center, USA



Editorial Board

Anil Sood
University of Texas MD Anderson Cancer Center, USA

Anthony T.C. Chan
The Chinese University of Hong Kong, China

Boris Pasche
Comprehensive Cancer Center of Wake Forest University, USA

Carl-Henrik Heldin
Uppsala University, Sweden

Carlos L. Arteaga
Vanderbilt-Ingram Cancer Center, Vanderbilt University, USA

Delia Mezzanzanica
Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

Dihua Yu
University of Texas MD Anderson Cancer Center, USA

Dong-Xin Lin
Chinese Academy of Medical Sciences, China

Er-Wei Song
Sun Yat-sen Memorial Hospital, China

Fang-Jian Zhou
Sun Yat-sen University Cancer Center, China

Gerry Melino
University of Rome, Italy

Gregory N. Fuller
University of Texas MD Anderson Cancer Center, USA

Guido Kroemer
INSERM, France

Ilya Shmulevich
Institute for Systems Biology, USA

Ingemar Ernberg
Karolinska Institute, Sweden

Jeff MacKeigan
Van Andel Research Institute, USA

Jian Zhang
Guangxi Medical University, China

Jian-Hua Fu
Sun Yat-sen University Cancer Center, China

Jie He
Chinese Academy of Medical Sciences, China

Joseph Wee
National Cancer Center, Singapore

Jun Ma
Sun Yat-sen University Cancer Center, China

Keng Shen
Peking Union Medical College, China

Ke-Xin Chen
Tianjin Medical University, China

Kwok Wai Lo
The Chinese University of Hong Kong, China

Laurence J.N. Cooper
University of Texas MD Anderson Cancer Center, USA

Lawrence S. Young
University of Birmingham, UK

Li Yan
GlaxoSmithKline PLC., UK

Li Zhang
Sun Yat-sen University Cancer Center, China

Li-Wu Fu
Sun Yat-sen University Cancer Center, China

Maria Masucci
Karolinska Institute, Sweden

Mikhail V. Blagosklonny
Roswell Park Cancer Institute, USA

Ming Zhou
Glickman Urological Institute, USA

Mu-Sheng Zeng
Sun Yat-sen University Cancer Center, China

Neal Rosen
Memorial Sloan-Kettering Cancer Center, USA

Olli Yli-Harja
Tampere University of Technology, Finland

Peng Huang
University of Texas MD Anderson Cancer Center, USA

Qian Tao
The Chinese University of Hong Kong, China

Qiang Liu
Sun Yat-sen University Cancer Center, China

René-O. Mirimanoff
University of Lausanne Medical Center,Switzerland

Richard Knight
Medical Research Council, UK

Sharlene Gill
BC Cancer Agency, Vancouver, Canada

Sheng-Ping Li
Sun Yat-sen University Cancer Center, China

Shiyuan Cheng
University of Pittsburgh Cancer Institute, USA

Sujuan Ba
National Foundation for Cancer Research, USA

Wan-Qing Chen
Peking Union Medical College, China

Webster K. Cavenee
University of California at San Diego, USA

Wei-Ping Zhou
University of Michigan, USA

Wen-Lin Huang
Sun Yat-sen University Cancer Center, China

Xiang-Xi (Mike) Xu
Sylvester Comprehensive Cancer Center, USA

Xiao-Feng Zhu
Sun Yat-sen University Cancer Center, China

Xiao-Ming Xie
Sun Yat-sen University Cancer Center, China

Ye-Xiong Li
Peking Union Medical College, China

Yi-Hai Cao
Karolinska Institute, Sweden

You-Lin Qiao
Peking Union Medical College, China

Yun-Fei Yuan
Sun Yat-sen University Cancer Center, China

Yunguang Tong
UCLA School of Medicine, USA

Zhe-Sheng Chen
St. John's University, USA

Zhi-Hua Liu
Peking Union Medical College, China

Zhi-Min Lu
University of Texas MD Anderson Cancer Center, USA

Zhi-Wei Zhou
Sun Yat-sen University Cancer Center, China

 





Awards to the Chinese Journal of Cancer


CJC Wins the Title of 2016’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2015’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2014’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2013’ the Highest International Impact Academic Journal of China


Certificate of Outstanding S&T Journals of China 2014
 

Top 100 Outstanding Scientific Journals in China in the 2010 Chinese S&T Journal Citation Reports by the Institute of Scientific and Technical Information of China
 

Grade A+ journals (top 5% among 6400 journals in China), in the Chinese Scientific Journal Evaluation Report by the Research Center for Chinese Science Evaluation
 

CJC wins the title of the 2012' Excellent International Impact Academic Journal of China
 

Outstanding S&T Journal of China 2011
 

Top one among 29 oncology journals in China, in the 2010 Impact Factor Report of Chinese Technical Journals,Life Sciences and Technology Version
 




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China